Long COVIDNCT05755542
Long-Covid in Patients Post Rehabilitation Treatment and Reintegration Into Everyday Life
An observational study of Long COVID, run by Rehazentrum Walenstadtberg.
Trial summary
The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Long COVID
- How many people
- 500 participants
- Where
- No sites listed yet
- Study dates
- 20 Mar 2023to 1 Nov 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Men and Women over 18 years of age who have been treated at Rehazentrum Walenstadtberg after being hospitilized primarily because of an acute Covid-19 infection
Who may be able to join
- >18 years of age
- treated at a rehabilitation facility after being hospitilized for covid-19 infection
- complete questionnaire
- written consent to use collected data
Who cannot join
- < 18 years
- incomplete questionnaire
Trial locations and contacts
No sites are listed yet.
Claudia von Felten, MD contact
About this study
Official title: Occurrence of Long-Covid in Patients After Inpatient Rehabilitation Due to Acute Covid-19 Infection. How Easy is it for Patients to Return to Everyday Life and Work After Inpatient Rehabilitation Due to Acute Covid-19-infection?
The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. 3 clusters of acute cases have been identified to be studied with regard to the long-term symptoms
- Mild course (medication, oxygen)
- Moderate course (IPS-IMC with NIV but without intubation)
- Severe course (intubation)
Read more
The aim of the second study is to use a catamnestic survey and subsequent evaluation of the information to gain an insight into the existing functional deficits relevant to everyday life and restriction of the ability to participate in the workplace after rehabilitation treatment. The assessment of functional deficits is carried out in relation to:
- Deficits in everyday skills (ADLs)
- Restrictions in the ability to participate in the profession.
Read the detailed description
All patients who had been infected with Walenstadtberg after acute Covid infection were included.
Patients were hospitalized for inpatient rehabilitation in the period from 01.04.2020 to 30.06.2022.
A written follow-up survey was carried out with regard to a possible persistent long Covid symptoms and possible persistent deficits in everyday skills and Restrictions in the ability to participate in the profession. There are 2 cohort studies.
- Conditions
- Long COVID
- Medical subject headings
- Post-Acute COVID-19 Syndrome
What is being measured
The primary outcome is the main question the study is designed to answer.
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
Measured: 2 years
Occurance of deficits in managing everyday life and work after covid infection
Investigation of deficits experienced by patients who have been treated at a rehabilitation facility after beeing hospitilized for a covid-19 infection and the impact of these deficits in everday life as well as in the workplace
Measured: 2 years
Secondary outcomes (2)
reinfection with covid-19 after rehabilition treatment
reinfection with covid-19 after rehabilition treatment
Measured: 2 years
Impact of Covid-19 infection on quality of life
Impact of Covid-19 infection on quality of life in patients who have been treated at a rehabilition facility after beeing hospitilized due to a covid-19 infection
Measured: 2 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Mar 2023
- Study start20 Mar 2023 (estimated)
- Primary completion1 Sep 2023 (estimated)
- Study completion1 Nov 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Long COVIDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rehazentrum Walenstadtberg
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Stefan Bachman, Prof., Study director, Rehazentrum Walenstadtberg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05755542
- Sponsor's protocol ID
- Covid Outcome
- Status last verified
- Mar 2023
- First submitted
- 1 Mar 2023
- Last updated
- 6 Mar 2023
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Occurrence of Long-Covid in Patients After Inpatient Rehabilitation Due to Acute Covid-19 Infection. How Easy is it for Patients to Return to Everyday Life and Work After Inpatient Rehabilitation Due to Acute Covid-19-infection?
- ClinicalTrials.gov ID
- NCT05755542
- Acronym / sponsor ID
- Covid Outcome
- Conditions
- Long COVID
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Rehazentrum WalenstadtbergUniversity, hospital or other
- Study start
- 20 Mar 2023 (estimated)
- Primary completion
- 1 Sep 2023 (estimated)
- Study completion
- 1 Nov 2023 (estimated)
- First posted
- 6 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the first study is to investigate how often a long Covid syndrome occurs after an inpatient rehabilitation due to previous hospitalization because of after acute Covid and whether there might be a connection with the severity during acute illness. 3 clusters of acute cases have been identified to be studied with regard to the long-term symptoms
- Mild course (medication, oxygen)
- Moderate course (IPS-IMC with NIV but without intubation)
- Severe course (intubation)
The aim of the second study is to use a catamnestic survey and subsequent evaluation of the information to gain an insight into the existing functional deficits relevant to everyday life and restriction of the ability to participate in the workplace after rehabilitation treatment. The assessment of functional deficits is carried out in relation to:
- Deficits in everyday skills (ADLs)
- Restrictions in the ability to participate in the profession.
Detailed description
All patients who had been infected with Walenstadtberg after acute Covid infection were included.
Patients were hospitalized for inpatient rehabilitation in the period from 01.04.2020 to 30.06.2022.
A written follow-up survey was carried out with regard to a possible persistent long Covid symptoms and possible persistent deficits in everyday skills and Restrictions in the ability to participate in the profession. There are 2 cohort studies.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Men and Women over 18 years of age who have been treated at Rehazentrum Walenstadtberg after being hospitilized primarily because of an acute Covid-19 infection
Key inclusion criteria (4 listed)
- >18 years of age
- treated at a rehabilitation facility after being hospitilized for covid-19 infection
- complete questionnaire
- written consent to use collected data
Key exclusion criteria (2 listed)
- < 18 years
- incomplete questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
Time frame: 2 years
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment
Occurance of deficits in managing everyday life and work after covid infection
Time frame: 2 years
Investigation of deficits experienced by patients who have been treated at a rehabilitation facility after beeing hospitilized for a covid-19 infection and the impact of these deficits in everday life as well as in the workplace
2 secondary outcomes
reinfection with covid-19 after rehabilition treatment
Time frame: 2 years
Impact of Covid-19 infection on quality of life
Time frame: 2 years
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Mar 2023.
- Individual participant dataSharing planned: No
Related trials for Long COVID
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Recruiting
Whole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study
ME/CFS, Fibromyalgia (FM)
Not yet recruitingPhase 3
The Study of Brave-LC LDN Treatment Trial
Post-acute COVID-19 Syndrome
Active, not recruitingObservational study
Epigenetic Changes in Long COVID Patients
Long COVID-19 Syndrome, Long COVID Symptoms
Enrolling by invitationPhase 2
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
Systemic Inflammation, Neuroinflammation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Claudia von Felten, MD contact
Stefan Bachman, Prof. study director
Rehazentrum Walenstadtberg
Questions about this trial
What is this clinical trial studying?
An observational study of Long COVID, run by Rehazentrum Walenstadtberg.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Jaroslaw A Dudczak, MD (0041793414160, jaroslaw.dudczak@kliniken-valens.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Occurance of Symptoms pointing at Long-Covid after rehabilitation treatment (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Mar 2023.